Tanespimycin Production Cost Analysis 2020

Tanespimycin, also known as 17-N-allylamino-17-demethoxygeldanamycin or 17-AAG, is a derivative of the antibiotic geldanamycin, which is used while studying the treatment of cancer, particularly in the younger patients with certain types of leukaemia or solid tumours, especially the kidney tumours. It belongs to the family of drugs, which are better known as antitumor antibiotics. It is a less toxic analogue as compared to geldanamycin. 

Tanespimycin is an antineoplastic agent and an apoptosis inducer. It has been developed to treat multiple cancer types, chronic myelogenous leukemia, and solid tumours. It works by inhibiting HSP90, which is expressed in those tumours. HSP90 helps keep many oncogenic signalling proteins stable, along with maintaining their functional shape. These maybe overexpressed in tumour cells; thus, by inhibiting HSP90, tanespimycin encourages its proteasomal degradation. 

Procurement Resource provides an in-depth cost analysis of Tanespimycin production. The report incorporates the manufacturing process with detailed process and material flow, capital investment, operating costs along with financial expenses and depreciation charges. The study is based on the latest prices and other economic data available. We also offer additional analysis of the report with detailed breakdown of all cost components (Capital Investment Details, Production Cost Details, Economics for another Plant Location, Dynamic Cost Model).


Tanespimycin Production from Corn
  • Tanespimycin Production from Corn

    This report presents an up-to-date, detailed cost analysis of Tanespimycin production from corn. The process examined is a typical fermentation process.

    Analysis Basis: Germany

    Period of Analysis: Q3 2020

    Starting at USD 1799

Related Reports

Acetaminophen Production from Phenol
  • Acetaminophen Production from Phenol

    This report presents a detailed cost analysis of acetaminophen production from phenol. In this process, phenol is first nitrated to produce a mixture of ortho and para-nitrotoluene.

    Analysis Basis: Germany

    Period of Analysis: Q3 2020

    Starting at USD 1799

Lactoflavin Production from Fermentation Process

Procurement Resource

Supply Demand and Market Analysis

Feasibility Studies

Techno-economic Evaluations

Investment Analysis

Multi-regional Cost Analyses

Evaluate Other Plant Locations

This report presents an analysis of capital and operating costs of a -based industrial plant. For those interested in economic assessments considering other plant locations, Procurement Resource offers optional analyses that complement this report.